Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.89 |
| ▸ | GAA | P10253 | 5/20 | 0.89 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.89 |
| ▸ | HSD17B3 | P37058 | 11/20 | 0.79 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.58 |
| ▸ | LCK | P06239 | 1/20 | 0.58 |
| ▸ | FYN | P06241 | 1/20 | 0.58 |
| ▸ | GRB2 | P62993 | 1/20 | 0.58 |
| ▸ | PPARG | P37231 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.56 |
| ▸ | GLA | P06280 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | CA12 | O43570 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29558522 | 1.00 | ALDH1A1 (0.89) | ALDH1A1GAAERAP1HSD17B3AKR1B1 | |
| SCHEMBL536846 | 0.88 | HSD17B3 (1.00) | ALDH1A1GAAERAP1HSD17B3AKR1B1 | |
| SCHEMBL3762732 | 0.84 | HSD17B3 (1.00) | ALDH1A1GAAERAP1HSD17B3AKR1B1 | |
| SCHEMBL8593488 | 0.83 | SRC (0.64) | ALDH1A1GAAERAP1HSD17B3KDM4E | |
| SCHEMBL8597998 | 0.83 | SRC (0.64) | ALDH1A1GAAERAP1HSD17B3KDM4E | |
| SCHEMBL8594946 | 0.83 | SRC (0.64) | ALDH1A1GAAERAP1HSD17B3KDM4E | |
| SCHEMBL18032945 | 0.83 | ALDH1A1 (0.62) | ALDH1A1GAAERAP1HSD17B3AKR1B1 | |
| SCHEMBL6257881 | 0.82 | ALDH1A1 (0.65) | ALDH1A1GAAERAP1HSD17B3AKR1B1 | |
| SCHEMBL14618025 | 0.82 | ALDH1A1 (0.69) | ALDH1A1GAAERAP1HSD17B3AKR1B1 | |
| SCHEMBL3127680 | 0.82 | ALDH1A1 (0.64) | ALDH1A1GAAERAP1HSD17B3KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122070479-A | Ultrasonic indicating device and method for monitoring ultrasonic treatment | JP实验室股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| WO-2025090061-A1 | ULTRASONIC INDICATOR DEVICE AND METHOD FOR MONITORING ULTRASONICATION | JP LABORATORIES, INC. (US) | 2025-05-01 | — | — | WO | claimed |
| WO-2025075611-A1 | ULTRASONIC INDICATOR BASED ON EMULSION FORMATION | JP LABORATORIES, INC. (US) | 2025-04-10 | — | — | WO | claimed |
| US-8454991-B2 | Method and device for photodynamic therapy | QUEST PHARMATECH INC. | 2013-06-04 | — | — | US | claimed |
| US-20110104781-A1 | ISOLATED PHOSPHOLIPID-PROTEIN PARTICLES | Life Technologies Corporation (US) | 2011-05-05 | — | — | US | claimed |
| US-20100233782-A1 | ISOLATED PHOSPHOLIPID-PROTEIN PARTICLES | Life Technologies Corporation (US) | 2010-09-16 | — | — | US | claimed |
| EP-2118129-A2 | ISOLATED PHOSPHOLIPID-PROTEIN PARTICLES | Life Technologies Corporation (US) | 2009-11-18 | — | — | EP | claimed |
| US-20090204057-A1 | METHOD AND DEVICE FOR PHOTODYNAMIC THERAPY | QUEST PHARMATECH INC. (CA) | 2009-08-13 | — | — | US | claimed |
| US-20090161828-A1 | ISOLATED PHOSPHOLIPID-PROTEIN PARTICLES | LIFE TECHNOLOGIES (US) | 2009-06-25 | — | — | US | claimed |
| US-20080248565-A1 | ISOLATED PHOSPHOLIPID-PROTEIN PARTICLES | INVITROGEN CORPORATION (US) | 2008-10-09 | — | — | US | claimed |
| WO-2008106660-A2 | ISOLATED PHOSPHOLIPID-PROTEIN PARTICLES | INVITROGEN CORPORATION (US) | 2008-09-04 | — | — | WO | claimed |
| WO-2008011707-A1 | METHOD AND DEVICE FOR PHOTODYNAMIC THERAPY | QUEST PHARMATECH INC. (CA) | 2008-01-31 | — | — | WO | claimed |
| EP-1039834-B1 | OPTOACOUSTIC CONTRAST AGENTS AND METHODS FOR THEIR USE | IMARX PHARMACEUTICAL CORP (US) | 2005-09-28 | — | — | EP | claimed |
| EP-1039834-A4 | OPTOACOUSTIC CONTRAST AGENTS AND METHODS FOR THEIR USE | IMARX PHARMACEUTICAL CORP (US) | 2001-12-05 | — | — | EP | claimed |
| EP-1039834-A1 | OPTOACOUSTIC CONTRAST AGENTS AND METHODS FOR THEIR USE | IMARX PHARMACEUTICAL CORP. (US) | 2000-10-04 | — | — | EP | claimed |
| US-6123923-A | ADMINISTERING A PATIENT A CONTRAST AGENT CONTAINING A STABILIZER, A PHOTOACTIVE AGENT, A GASEOUS PRECURSOR SUCH AS PERFLUORINATED COMPOUND OR GAS OR BOTH, AND SCANNING THE PATIENT USING ULTRASOUND IMAGING AND OPTICAL IMAGING | IMARX PHARMACEUTICAL CORP. (US) | 2000-09-26 | — | — | US | claimed |
| WO-1999030620-A1 | OPTOACOUSTIC CONTRAST AGENTS AND METHODS FOR THEIR USE | IMARX PHARMACEUTICAL CORP. (US) | 1999-06-24 | — | — | WO | claimed |
| CN-122070479-A | Ultrasonic indicating device and method for monitoring ultrasonic treatment | JP实验室股份有限公司 | 2026-05-19 | — | — | CN | disclosed |
| WO-1993018852-A1 | OIL-IN-WATER EMULSIONS OF POSITIVELY CHARGED PARTICLES | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 1993-09-30 | — | — | WO | disclosed |
| EP-0451719-A1 | Device for identifying at least one gaseous component in a gaseous or liquid sample, and identification method | HITACHI, LTD. (JP) | 1991-10-16 | — | — | EP | disclosed |